
|Articles|October 1, 2000
Supplements and Featured Publications
- Antibody-Targeted Chemotherapy for the Treatment of Relapsed Acute Myeloid Leukemia
- Volume 6
- Issue 18 Suppl
Commentary: New Research and Treatment Options for Acute Myeloid Leukemia
Author(s)Carole B. Miller, MD
Advertisement
Articles in this issue
about 25 years ago
Continuing Medical Education Quizabout 25 years ago
Overview: Treatment of Acute Myeloid LeukemiaNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Clinicians Cite Progress Tracking as Top Barrier in Value-Based Care
2
T-DXd Delivers Strong Breast Cancer Outcomes Across Groups
3
Genome-Wide Analysis Uncovers Genetic Drivers of IPF and Its Overlap With COVID-19
4
Camizestrant-Related Photopsia Mostly Mild, Nondisabling in Patients With Advanced Breast Cancer: Adam Brufsky, MD, PhD
5














































